Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Newer generation transcatheter heart valves (THV) are presumed to yield better clinical
efficacy and postprocedural complication profile as compared to transcatheter aortic valve …

Objectives The goal of this study is to analyze the evolution of technology in artificial heart
valves for solving the problem of aortic stenosis (a narrowing of the aortic valve opening) …

Background The treatment of aortic stenosis is evolving rapidly. Pace of change in the care
of patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic …

Objectives Guidelines suggest aortic valve replacement (AVR) for low-risk asymptomatic
patients. Indications for transcatheter AVR now include low-risk patients, making it …

Background Transcatheter aortic valve replacement (TAVR) has become the standard of
care for a wide spectrum of patients with severe aortic stenosis. However, there are wide …

Infective endocarditis (IE) is a serious infection and causes significant morbidity and
mortality. However, the benefit of surgery for endocarditis besides antibiotic treatment in …

Background Surgical aortic valve replacement (SAVR) is an established therapy for severe
calcific aortic stenosis. Enhanced recovery after cardiac surgery (ERACS) protocols have …

Volume-outcome relations exist for transcatheter aortic valve replacement (TAVR) and mitral
transcatheter edge-to-edge repair (TEER), but how the volume of one impacts the outcomes …

The association between hospital volume and clinical outcomes has been well established
in the field of surgical aortic valve replacement (SAVR). 1 The so-called 'volume–outcome …